Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut 
BlueScope Steel Shares Slip After Board Rejects A$13.2 Billion Takeover Bid 
OpenAI Sets $50 Billion Stock Grant Pool, Boosting Employee Equity and Valuation Outlook 
Trump Pushes $100 Billion U.S. Oil Investment Plan for Venezuela After Maduro Seizure 
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids 
Johnson & Johnson Secures Tariff Exemption by Agreeing to Lower Drug Prices in the U.S. 
AustralianSuper Backs BlueScope Steel’s Rejection of $9 Billion Takeover Bid 
Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026 
Rio Tinto–Glencore Merger Talks Spark Investor Debate Over Value, Strategy and Coal Exposure 
EU Orders Elon Musk’s X to Preserve Grok AI Data Amid Probe Into Illegal Content 
Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal 
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside 
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability 
Ford Targets Level 3 Autonomous Driving by 2028 with New EV Platform and AI Innovations 
FCC Approves Expansion of SpaceX Starlink Network With 7,500 New Satellites 
Hanwha Ocean Shares Rise on Plans to Expand U.S. Shipbuilding Capacity 
TeamHealth has shut down a private merger offer from AmSurg Corp. TeamHealth is a hospital staffing company while AmSurg aids in running clinics and surgery centers, Bloomberg said. This was announced shortly after the latter has announced that it is engaging with TeamHealth on Tuesday, Reuters said. The offer was at USD5.3 billion at USD71.47 per share, of which TeamHealth is quick to retort that the offer is undervalued. It was noted that the offer was at a 36 percent premium of TeamHealth’s closing price on Monday.
Under the terms of the merger offer, the new company will assume the TeamHealth name and will continue to operate from its headquarters in Knoxville, Tennessee, Street Insider reports. Moreover, the Board of Directors will be filled with representatives from both companies, with AmSurg President and Chief Executive Officer Christopher Holden acting as the new CEO.
In a letter addressed to the members of TeamHealth’s Board, Holden said, “We are disappointed to learn that you chose not to engage with us based on what appears to be a very cursory analysis of our specific proposal and key deal terms.”
If the merger happened, the new company will have about 1,200 health-care facilities and 20,000 clinical workers in its stead, Amsurg said.
